Analyst stock forecast
Zenas BioPharma Forecast: $47.88 Analyst Target
Direct answer
Zenas BioPharma's average price target is $47.88.
The target implies +75.6% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +17.4%, the high target implies +116.4%, and the range spans 99% of the current price.
Forecast evidence checked October 10, 2026.
Get free Zenas BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $27.26
- Average price target
- $47.88
- High price target
- $59.00
- Low price target
- $32.00
- Low target gap
- +17.4%
- Target upside
- +75.6%
- High target gap
- +116.4%
- Target range width
- 99%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- October 10, 2026
- Valid through
- October 17, 2026
Explore related company data
Read the frequently asked questions.
What is Zenas BioPharma's average price target?
Zenas BioPharma's verified average price target is $47.88. The target range is $32.00 to $59.00.
How far are Zenas BioPharma's low and high targets from the recorded price?
The low target implies +17.4%, while the high target implies +116.4%.
How many analysts are included in Zenas BioPharma's consensus?
The verified consensus includes 8 analysts.
How is Zenas BioPharma's target upside or downside calculated?
The average target of $47.88 is divided by the recorded price of $27.26, then one is subtracted to produce +75.6%. This does not guarantee a future return.
When was Zenas BioPharma's analyst forecast verified?
The data was verified on 2026-10-10. The dataset is valid through 2026-10-17.